Quercetin and metabolic syndrome: A review

被引:277
作者
Hosseini, Azar [1 ]
Razavi, Bibi Marjan [2 ,3 ]
Banach, Maciej [4 ]
Hosseinzadeh, Hossein [3 ,5 ]
机构
[1] Mashhad Univ Med Sci, Pharmacol Res Ctr Med Plants, Mashhad, Razavi Khorasan, Iran
[2] Mashhad Univ Med Sci, Targeted Drug Delivery Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran
[3] Mashhad Univ Med Sci, Sch Pharm, Dept Pharmacodynam & Toxicol, Mashhad, Razavi Khorasan, Iran
[4] Med Univ Lodz, Dept Hypertens, Lodz, Poland
[5] Mashhad Univ Med Sci, Pharmaceut Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran
关键词
diabetes; dyslipidemia; hypertension; metabolic syndrome; obesity; quercetin; HIGH-FAT DIET; FLAVONOID QUERCETIN; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; BLOOD-PRESSURE; INDUCED INFLAMMATION; LIPID-METABOLISM; DOUBLE-BLIND; RISK-FACTORS; ANTIOXIDANT;
D O I
10.1002/ptr.7144
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Metabolic syndrome (MetS) is a complex of diseases that lead to mortality due to the development of cardiovascular problems. Quercetin, as an important flavonoid, has various properties such as decreasing blood pressure, anti-hyperlipidemia, anti-hyperglycemia, anti-oxidant, antiviral, anticancer, anti-inflammatory, anti-microbial, neuroprotective, and cardio-protective effects. In this review article, we collected original articles from different sources such as Google Scholar, Medline, Scopus, and Pubmed, which is related to the effect of quercetin on the improvement of the signs of MetS, including elevated glucose level, hyperlipidemia, obesity, and blood pressure. According to these data, quercetin may also have a role in the management of metabolic disorders via different mechanisms such as increasing adiponectin, decreasing leptin, anti-oxidant activity, reduction of insulin resistance, the elevation of insulin level, and blocking of calcium channel. We have attempted to make some recommendations on the quercetin application in patients. However, it needs to do further clinical trials and more investigations to show the real clinical value of quercetin on metabolic syndrome.
引用
收藏
页码:5352 / 5364
页数:13
相关论文
共 126 条
[1]   Confirmatory studies on the antioxidant and antidiabetic effect of quercetin in rats [J].
Abdelmoaty M.A. ;
Ibrahim M.A. ;
Ahmed N.S. ;
Abdelaziz M.A. .
Indian Journal of Clinical Biochemistry, 2010, 25 (2) :188-192
[2]  
Abuzaid A.A., 2017, J PHARM SCI EMERGING, V4, P2, DOI [10.4172/2380-9477.1000117, DOI 10.4172/2380-9477.1000117]
[3]  
Aguirre L., 2011, The Open Nutraceuticals Journal, V4, DOI DOI 10.2174/1876396001104010189
[4]   The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways [J].
Ahn, Jiyun ;
Lee, Hyunjung ;
Kim, Suna ;
Park, Jaeho ;
Ha, Taleyoul .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 373 (04) :545-549
[5]   Grapes (Vitis vinifera) as a Potential Candidate for the Therapy of the Metabolic Syndrome [J].
Akaberi, Maryam ;
Hosseinzadeh, Hosein .
PHYTOTHERAPY RESEARCH, 2016, 30 (04) :540-556
[6]  
Anand David Alexander Victor, 2016, Pharmacogn Rev, V10, P84, DOI 10.4103/0973-7847.194044
[7]   Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats [J].
Anjaneyulu, M ;
Chopra, K .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (04) :244-248
[8]  
Arai Y, 2000, J NUTR, V130, P2243
[9]  
Arun K, 2013, INT J PHARM SCI BIOM, V2, P219
[10]   Synergistic effect of quercetin and quinic acid by alleviating structural degeneration in the liver, kidney and pancreas tissues of STZ-induced diabetic rats: A mechanistic study [J].
Arya, Aditya ;
Al-Obaidi, Mazen M. Jamil ;
Shahid, Nayiar ;
Bin Noordin, Mohamed Ibrahim ;
Looi, Chung Yeng ;
Wong, Won Fen ;
Khaing, Si Lay ;
Mustafa, Mohd Rais .
FOOD AND CHEMICAL TOXICOLOGY, 2014, 71 :183-196